Transarterial microembolization (TAME) for inflamed knee osteoarthritis
Official title: "Transarterial Microembolization (TAME) in Inflammatory Knee Pathology: Prospective Observational Study."
Run by Istituto Ortopedico Rizzoli · NCT07140367 · Data updated 2026-11-12
This project will try selective arterial embolization (TAME) to reduce chronic pain in adults with moderate inflammatory knee osteoarthritis who have not improved after at least three months of conservative care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 43 (estimated) |
| Sponsor | Istituto Ortopedico Rizzoli Academic / other |
| Locations | 1 site (Bologna, Bologna) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | September 1, 2029 |
| Study ends | September 1, 2031 |
| Registry record updated | April 7, 2026 |
| Trial ID | NCT07140367 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 40 with moderate (KL 2-3) knee osteoarthritis with inflammatory signs, persistent moderate-to-severe pain (VAS >4), and documented failure of at least three months of conservative therapies.
✕Probably not a fit
Patients with severe end-stage OA, rheumatic diseases, recent knee trauma, active malignancy, or other exclusion conditions listed by the investigators are less likely to benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will enroll 43 patients with moderate (Kellgren-Lawrence grade 2-3) knee osteoarthritis with inflammatory features and persistent pain despite at least three months of conservative therapy. Enrolled patients will undergo transarterial microembolization (selective arterial embolization) and be followed with clinical evaluations at 1, 3, 6, 12, and 24 months or until dropout. Outcomes will focus on pain, functional status, and safety signals after the embolization procedure. The protocol uses multidisciplinary eligibility review and is conducted at IRCCS Istituto Ortopedico Rizzoli in Bologna.
Why it matters
Potential benefit: If successful, the procedure could reduce knee pain and improve function, potentially delaying or reducing the need for knee replacement surgery.
How similar studies have gone: Related techniques such as genicular artery embolization have shown promising pain reduction in small series, but evidence remains limited and not yet definitive.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Patients with degenerative knee disease: 1. Age over 40 years; 2. Moderate knee OA (grade 2-3 according to the Kellgren-Lawrence score) for which an indication for total knee arthroplasty surgery has already been given; 3. Knee OA with an inflammatory component (night pain, pain at rest, recurrent episodes of effusion, swelling and/or redness); 4. Persistent and moderate or severe knee pain (VAS score \> 4); 5. Failure after at least 3 months of conservative therapies (e.g., physical therapy, drug therapy with NSAIDs and pain relievers, hyaluronic acid infiltration, corticosteroids, or orthobiologics). 6. Signature of informed consent 7. Case declared eligible for treatment following discussion at internal multidisciplinary meeting on degenerative-inflammatory disease Exclusion Criteria: 1. Mentally incompetent patients; 2. Patients with trauma in the 6 months prior to treatment; 3. Patients with malignant neoplasms; 4. Patients with rheumatic diseases; 5. Patients on anticoagulant-antiaggregant therapy (including if therapy can be discontinued 5 days earlier); 6. Patients abusing alcoholic beverages, drugs, or medications; 7. Patients undergoing surgery of the affected knee in the previous 12 months; 8. INR \<2; 9. Platelet count \<30,000; 10. Renal function: GFR\<30ml/min; 11. Pregnancy; 12. Allergy to iodinated contrast. 13. Ineligibility to perform MRI examination.
Where it's running
-
IRCCS Istituto Ortopedico Rizzoli
Bologna, Bologna, Italy Recruiting
Study contacts
- Study coordinator: Giancarlo Facchini, Medicine and Surgery
- Email: giancarlo.facchini@ior.it
- Phone: +39 0516366836
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NPT Feasibility in Knee Osteoarthritis
This study tests whether NRPT can be safely given to adults with knee osteoarthritis and whether it shows early signals of benefit.
-
Aquatic exercise for knee osteoarthritis and central sensitization
A water-based exercise program is being tested to see if it helps people aged 40–65 with knee osteoarthritis who also have central sensitization.
-
Gender-based test of a graded weight-bearing physiotherapy for knee osteoarthritis
We’re testing a 6-week, sensory-modulated graded weight-bearing physiotherapy to see if outcomes differ between men and women with knee osteoarthritis.
-
Does implant type affect knee alignment when using KUNWU robotic surgery
This trial tests whether two knee implants (Attune vs Persona) used with the KUNWU robotic system result in more accurate knee alignment after total knee replacement.
-
Outpatient physiotherapy vs. mHealth exercise and self-management for knee osteoarthritis
This study tests whether a mobile app–guided, self-managed knee OA exercise program is as good as traditional hospital-based therapy for improving walking speed in adults with knee OA.
-
Digital Rehab Program for knee OA using multisensory gear and digital twin tech
A digital rehabilitation program with a smart knee brace and real-time feedback is tested to help adults with knee OA improve movement and function at home.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.